サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1386283

がんワクチン市場レポート：2030年までの動向、予測、競合分析

Cancer Vaccine Market Report: Trends, Forecast and Competitive Analysis to 2030
出版日: | 発行: Lucintel | ページ情報: 英文 150 Pages | 納期: 3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円

ご注意:　DRM (デジタル著作権管理システム) 付PDFになります。
制限内容は、上記ライセンスの[詳細]アイコンをクリックしてご確認ください。

がんワクチン市場レポート：2030年までの動向、予測、競合分析
出版日: 2023年10月03日
発行: Lucintel
ページ情報: 英文 150 Pages
納期: 3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 目次
概要

がんワクチンの動向と予測

世界のがんワクチン市場は、2024年から2030年までのCAGRが10.5%で、2030年までに推定155億米ドルに達すると予想されます。この市場の主な促進要因は、より効果的で侵襲性の低いがん治療に対する需要の高まり、がんワクチンの利点に対する認識の高まり、がんワクチン接種を促進するための政府の支援策などです。世界のがんワクチン市場の将来は、病院および政府供給チャネルにおける機会によって有望視されています。

がんワクチン市場の洞察

Lucintelの予測によると、がんの発症を未然に防ぐ予防ワクチンが、予測期間中に最も高い成長を遂げる見込みです。

この市場の中では、病院でがんの診断と治療を受ける人が増加しているため、病院が予測期間中に高い成長を遂げると予測されます。

北米は、がん患者数の増加と確立されたヘルスケアシステムの存在により、予測期間中に最も高い成長が見込まれています。

本レポートでは、以下の11の主要な質問に回答している：

  • Q.1.市場セグメントのうち、最も有望かつ高成長な機会は何か？
  • Q.2.どのセグメントがより速いペースで成長するのか、またその理由は？
  • Q.3.今後成長が加速すると思われる地域とその理由は？
  • Q.4.市場力学に影響を与える主な要因は何か？市場における主な課題とビジネスリスクは？
  • Q.5.この市場におけるビジネスリスクと競合の脅威は？
  • Q.6.この市場における新たな動向とその理由は？
  • Q.7.市場における顧客の需要の変化にはどのようなものがありますか？
  • Q.8.この市場における新たな開発と、その開発をリードしている企業は？
  • Q.9.この市場における主要企業は？主要企業は事業成長のためにどのような戦略的取り組みを進めているのか？
  • Q.10.この市場における競合製品にはどのようなものがあり、材料や製品の代替による市場シェア低下の脅威はどの程度ありますか？
  • Q.11.過去5年間にどのようなM&Aが行われ、業界にどのような影響を与えましたか？

目次

第1章 エグゼクティブサマリー

第2章 世界のがんワクチン市場：市場力学

  • イントロダクション、背景、分類
  • サプライチェーン
  • 業界の促進要因と課題

第3章 2018年から2030年までの市場動向と予測分析

  • マクロ経済動向（2018～2023年）と予測（2024～2030年）
  • 世界のがんワクチン市場動向（2018～2023年）と予測（2024～2030年）
  • ワクチンタイプ別の世界のがんワクチン市場
    • 予防
    • 治療用
  • 技術別の世界のがんワクチン市場
    • 組換え
    • 全細胞
    • ウイルスベクター
    • DNAがんワクチン
  • 流通チャネル別の世界のがんワクチン市場
    • 病院
    • 政府のサプライヤー

第4章 2018年から2030年までの地域別の市場動向と予測分析

  • 地域別の世界のがんワクチン市場
  • 北米のがんワクチン市場
  • 欧州がんワクチン市場
  • アジア太平洋がんワクチン市場
  • その他地域がんワクチン市場

第5章 競合の分析

  • 製品ポートフォリオ分析
  • 運用上の統合
  • ポーターのファイブフォース分析

第6章 成長機会と戦略的分析

  • 成長機会分析
    • ワクチンタイプ別の世界のがんワクチン市場の成長機会
    • 技術別の世界のがんワクチン市場の成長機会
    • 流通チャネル別の世界のがんワクチン市場の成長機会
    • 地域別の世界のがんワクチン市場の成長機会
  • 世界のがんワクチン市場の新たな動向
  • 戦略的分析
    • 新製品の開発
    • 世界のがんワクチン市場の能力拡大
    • 世界のがんワクチン市場における合併、買収、合弁事業
    • 認証とライセンシング

第7章 有力企業の企業プロファイル

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • AstraZeneca
  • Bristol-Myers Squibb
目次

Cancer Vaccine Trends and Forecast

The future of the global cancer vaccine market looks promising with opportunities in the hospital and government supplier channels. The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030 with a CAGR of 10.5% from 2024 to 2030. The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

A more than 150-page report is developed to help in your business decisions.

Cancer Vaccine by Segment

The study includes a forecast for the global cancer vaccine by vaccine type, technology, distribution channel, and region.

Cancer Vaccine Market by Vaccine Type [Shipment Analysis by Value from 2018 to 2030]:

  • Preventive
  • Therapeutic

Cancer Vaccine Market by Technology [Shipment Analysis by Value from 2018 to 2030]:

  • Recombinant
  • Whole-Cell
  • Viral Vector
  • DNA Cancer Vaccines

Cancer Vaccine Market by Distribution Channel [Shipment Analysis by Value from 2018 to 2030]:

  • Hospitals
  • Government Suppliers

Cancer Vaccine Market by Region [Shipment Analysis by Value from 2018 to 2030]:

  • North America
  • Europe
  • Asia Pacific
  • The Rest of the World

List of Cancer Vaccine Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies cancer vaccine companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the cancer vaccine companies profiled in this report include-

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Cancer Vaccine Market Insights

Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Within this market, hospital is expected to witness higher growth over the forecast period due to the increasing number of individuals seeking cancer diagnosis and treatment in hospitals.

North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Features of the Global Cancer Vaccine Market

Market Size Estimates: Cancer vaccine market size estimation in terms of value ($B).

Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.

Segmentation Analysis: Cancer vaccine market size by vaccine type, technology, distribution channel, and region in terms of value ($B).

Regional Analysis: Cancer vaccine market breakdown by North America, Europe, Asia Pacific, and Rest of the World.

Growth Opportunities: Analysis of growth opportunities in different vaccine types, technologies, distribution channels, and regions for the cancer vaccine market.

Strategic Analysis: This includes M&A, new product development, and competitive landscape of the cancer vaccine market.

Analysis of competitive intensity of the industry based on Porter's Five Forces model.

FAQ

Q.1 What is the cancer vaccine market size?

Answer: The global cancer vaccine market is expected to reach an estimated $15.5 billion by 2030.

Q.2 What is the growth forecast for cancer vaccine market?

Answer: The global cancer vaccine market is expected to grow with a CAGR of 10.5% from 2024 to 2030.

Q.3 What are the major drivers influencing the growth of the cancer vaccine market?

Answer: The major drivers for this market are rising demand for more effective and less invasive cancer treatment, growing awareness of the benefits of cancer vaccines, and supportive government initiatives to promote cancer vaccination.

Q4. What are the major segments for cancer vaccine market?

Answer: The future of the cancer vaccine market looks promising with opportunities in the hospital and government supplier channels.

Q5. Who are the key cancer vaccine market companies?

Answer: Some of the key cancer vaccine companies are as follows:

  • Merck
  • GSK
  • Dendreon Pharmaceuticals
  • Dynavax Technologies
  • Ferring
  • Amgen
  • Moderna
  • Sanofi
  • Astrazeneca
  • Bristol-Myers Squibb

Q6. Which cancer vaccine market segment will be the largest in future?

Answer: Lucintel forecasts that preventive is expected to witness highest growth over the forecast period due to its ability to prevent cancer from developing in the first place.

Q7. In cancer vaccine market, which region is expected to be the largest in next 5 years?

Answer: North America is expected to witness highest growth over the forecast period due to the rising number of cancer patients and presence of well-established healthcare system in the region.

Q.8 Do we receive customization in this report?

Answer: Yes, Lucintel provides 10% customization without any additional cost.

This report answers following 11 key questions:

  • Q.1. What are some of the most promising, high-growth opportunities for the cancer vaccine market by vaccine type (preventive and therapeutic), technology (recombinant, whole-cell, viral vector, and dna cancer vaccines), distribution channel (hospitals and government suppliers), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
  • Q.2. Which segments will grow at a faster pace and why?
  • Q.3. Which region will grow at a faster pace and why?
  • Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
  • Q.5. What are the business risks and competitive threats in this market?
  • Q.6. What are the emerging trends in this market and the reasons behind them?
  • Q.7. What are some of the changing demands of customers in the market?
  • Q.8. What are the new developments in the market? Which companies are leading these developments?
  • Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
  • Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
  • Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?

Table of Contents

1. Executive Summary

2. Global Cancer Vaccine Market : Market Dynamics

  • 2.1: Introduction, Background, and Classifications
  • 2.2: Supply Chain
  • 2.3: Industry Drivers and Challenges

3. Market Trends and Forecast Analysis from 2018 to 2030

  • 3.1. Macroeconomic Trends (2018-2023) and Forecast (2024-2030)
  • 3.2. Global Cancer Vaccine Market Trends (2018-2023) and Forecast (2024-2030)
  • 3.3: Global Cancer Vaccine Market by Vaccine Type
    • 3.3.1: Preventive
    • 3.3.2: Therapeutic
  • 3.4: Global Cancer Vaccine Market by Technology
    • 3.4.1: Recombinant
    • 3.4.2: Whole-Cell
    • 3.4.3: Viral Vector
    • 3.4.4: DNA Cancer Vaccines
  • 3.5: Global Cancer Vaccine Market by Distribution Channel
    • 3.5.1: Hospitals
    • 3.5.2: Government Suppliers

4. Market Trends and Forecast Analysis by Region from 2018 to 2030

  • 4.1: Global Cancer Vaccine Market by Region
  • 4.2: North American Cancer Vaccine Market
    • 4.2.2: North American Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.3: European Cancer Vaccine Market
    • 4.3.1: European Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.3.2: European Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.4: APAC Cancer Vaccine Market
    • 4.4.1: APAC Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.4.2: APAC Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers
  • 4.5: ROW Cancer Vaccine Market
    • 4.5.1: ROW Cancer Vaccine Market by Vaccine Type: Preventive and Therapeutic
    • 4.5.2: ROW Cancer Vaccine Market by Distribution Channel: Hospitals and Government Suppliers

5. Competitor Analysis

  • 5.1: Product Portfolio Analysis
  • 5.2: Operational Integration
  • 5.3: Porter's Five Forces Analysis

6. Growth Opportunities and Strategic Analysis

  • 6.1: Growth Opportunity Analysis
    • 6.1.1: Growth Opportunities for the Global Cancer Vaccine Market by Vaccine Type
    • 6.1.2: Growth Opportunities for the Global Cancer Vaccine Market by Technology
    • 6.1.3: Growth Opportunities for the Global Cancer Vaccine Market by Distribution Channel
    • 6.1.4: Growth Opportunities for the Global Cancer Vaccine Market by Region
  • 6.2: Emerging Trends in the Global Cancer Vaccine Market
  • 6.3: Strategic Analysis
    • 6.3.1: New Product Development
    • 6.3.2: Capacity Expansion of the Global Cancer Vaccine Market
    • 6.3.3: Mergers, Acquisitions, and Joint Ventures in the Global Cancer Vaccine Market
    • 6.3.4: Certification and Licensing

7. Company Profiles of Leading Players

  • 7.1: Merck
  • 7.2: GSK
  • 7.3: Dendreon Pharmaceuticals
  • 7.4: Dynavax Technologies
  • 7.5: Ferring
  • 7.6: Amgen
  • 7.7: Moderna
  • 7.8: Sanofi
  • 7.9: AstraZeneca
  • 7.10: Bristol-Myers Squibb